Wellington Management Group LLP Stoke Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 136,975 shares of STOK stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,975

Previous 143,636 4.64%

Holding current value

$1.58 Million

Previous $1.94 Million 13.25%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.24 - $15.92 $81,530 - $106,043	-6,661 Reduced 4.64%	136,975 $1.68 Million
Q2 2024 Aug 13, 2024	BUY	$11.03 - $17.52 $3,143 - $4,993	285 Added 0.2%	143,636 $1.94 Million
Q1 2024 May 15, 2024	BUY	$4.12 - $14.17 $590,606 - $2.03 Million	143,351 New	143,351 $1.94 Million
Q3 2023 Nov 14, 2023	BUY	$3.78 - $11.99 $19,066 - $60,477	5,044 Added 2.98%	174,332 $686,000
Q2 2023 Aug 14, 2023	SELL	$7.93 - $13.82 $250,659 - $436,836	-31,609 Reduced 15.73%	169,288 $1.8 Million
Q1 2023 May 12, 2023	SELL	$7.65 - $10.38 $3.15 Million - $4.27 Million	-411,157 Reduced 67.18%	200,897 $1.67 Million
Q4 2022 Feb 13, 2023	SELL	$7.07 - $15.69 $4.61 Million - $10.2 Million	-651,345 Reduced 51.55%	612,054 $5.65 Million
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $66,392 - $119,093	5,286 Added 0.42%	1,263,399 $16.2 Million
Q2 2022 Aug 15, 2022	BUY	$10.36 - $23.93 $725,179 - $1.68 Million	69,998 Added 5.89%	1,258,113 $16.6 Million
Q1 2022 May 16, 2022	BUY	$17.19 - $26.1 $20.4 Million - $31 Million	1,188,115 New	1,188,115 $25 Million
Q4 2020 Feb 12, 2021	SELL	$33.62 - $61.93 $1.84 Million - $3.39 Million	-54,750 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$22.23 - $37.48 $873,683 - $1.47 Million	39,302 Added 254.41%	54,750 $1.83 Million
Q2 2020 Aug 14, 2020	SELL	$20.26 - $29.73 $2.34 Million - $3.44 Million	-115,732 Reduced 88.22%	15,448 $368,000
Q1 2020 May 14, 2020	SELL	$16.8 - $34.15 $941,942 - $1.91 Million	-56,068 Reduced 29.94%	131,180 $3 Million
Q4 2019 Feb 11, 2020	BUY	$20.01 - $30.79 $3.75 Million - $5.77 Million	187,248 New	187,248 $5.3 Million

Others Institutions Holding STOK

# of Institutions

128

Shares Held

57.6M

Call Options Held

9.3K

Put Options Held

35.2K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $454M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Stoke Therapeutics, Inc. Transaction History